RESEARCH ARTICLE


Health Related Quality of Life in Patients with Onco-hematological Diseases



Giorgio La Nasa1, Giovanni Caocci1, *, Emanuela Morelli1, Elena Massa2, Antonio Farci2, Laura Deiana2, Elisa Pintus2, Mario Scartozzi2, Federica Sancassiani2
1 Ematologia e CTMO, Ospedale Businco, Azienda Ospedaliera Brotzu, Cagliari, Italy
2 Dipartimento di Scienze Mediche e Sanita Pubblica, Universita di Cagliari, Cagliari, Italy


Article Metrics

CrossRef Citations:
4
Total Statistics:

Full-Text HTML Views: 1556
Abstract HTML Views: 475
PDF Downloads: 237
Total Views/Downloads: 2268
Unique Statistics:

Full-Text HTML Views: 763
Abstract HTML Views: 240
PDF Downloads: 186
Total Views/Downloads: 1189



Creative Commons License
© 2020 La Nasa et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Ematologia e CTMO, Ospedale Businco, Azienda Ospedaliera Brotzu, Via Jenner, sn, 09124 Cagliari, Italy; Tel: +39-70-52964901; Fax: +39-70-52965317; E-mail: giovanni.caocci@unica.it


Abstract

Background:

HRQoL is generally conceptualized as a broad multidimensional construct that refers to patients' perceptions of the impact of disease and its treatment on their physical, psychological, and social functioning and well-being. Little is known in patients with onco-hematological cancer in comparison with the general population and other chronic diseases.

Objective:

We assessed HRQoL in patients diagnosed with haematological cancers in comparison with the general population and other chronic diseases.

Methods:

The questionnaire Short Form (SF)-12 was administered to 62 patients with onco-hematological disease and results were compared with 702 controls (184 healthy people, 37 Major Depression, 201 Multiple Sclerosis; 23 Wilson disease; 46 Carotidal Atherosclerosis; 60 Celiac disease; 151 solid tumours).

Results:

HRQoL in patients diagnosed with a haematological cancer was significantly worse in comparison with the general population (F= 43.853, p <0.00001) but similar when compared with solid tumour and other chronic diseases such as Major Depression and Carotid Atherosclerosis. In addition, HRQoL in patients diagnosed with a haematological cancer was significantly higher than that due to Celiac disease (p <0.00001) and Wilson's disease (p= 0.02), and lower than that due to Multiple Sclerosis (p= 0.032).

Conclusion:

This study confirmed that haematological cancers negatively affects overall HRQoL. The results showed an impact of haematological cancers on HRQoL that is similar to what found in patients with solid tumors, Major Depression and Carotid Atherosclerosis. Current successful therapeutic strategy achieved in the treatment of haematological cancers not only positively impact on survival rate but also could improve the overall HRQoL.

Keywords: HRQoL, Hematological cancer, Mood depression, SF-12, Multiple Sclerosis, Tumors, Celiac disease.